Transmembrane BAX Inhibitor-1 Motif Containing Protein 5 (TMBIM5) Sustains Mitochondrial Structure, Shape, and Function by Impacting the Mitochondrial Protein Synthesis Machinery
Bruno Seitaj,
Felicia Maull,
Li Zhang,
Verena Wüllner,
Christina Wolf,
Philipp Schippers,
Rita La Rovere,
Ute Distler,
Stefan Tenzer,
Jan B. Parys,
Geert Bultynck,
Axel Methner
Affiliations
Bruno Seitaj
KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut (LKI), Campus Gasthuisberg ON-I Bus 802, 3000 Leuven, Belgium
Felicia Maull
Institute for Molecular Medicine, Johannes Gutenberg University Medical Center Mainz, D-55131 Mainz, Germany
Li Zhang
Institute for Molecular Medicine, Johannes Gutenberg University Medical Center Mainz, D-55131 Mainz, Germany
Verena Wüllner
Institute for Molecular Medicine, Johannes Gutenberg University Medical Center Mainz, D-55131 Mainz, Germany
Christina Wolf
Institute for Molecular Medicine, Johannes Gutenberg University Medical Center Mainz, D-55131 Mainz, Germany
Philipp Schippers
Institute for Molecular Medicine, Johannes Gutenberg University Medical Center Mainz, D-55131 Mainz, Germany
Rita La Rovere
KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut (LKI), Campus Gasthuisberg ON-I Bus 802, 3000 Leuven, Belgium
Ute Distler
Institute for Immunology, Langenbeckstr. 1, D-55131 Mainz, Germany
Stefan Tenzer
Institute for Immunology, Langenbeckstr. 1, D-55131 Mainz, Germany
Jan B. Parys
KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut (LKI), Campus Gasthuisberg ON-I Bus 802, 3000 Leuven, Belgium
Geert Bultynck
KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut (LKI), Campus Gasthuisberg ON-I Bus 802, 3000 Leuven, Belgium
Axel Methner
Institute for Molecular Medicine, Johannes Gutenberg University Medical Center Mainz, D-55131 Mainz, Germany
The Transmembrane Bax Inhibitor-1 motif (TMBIM)-containing protein family is evolutionarily conserved and has been implicated in cell death susceptibility. The only member with a mitochondrial localization is TMBIM5 (also known as GHITM or MICS1), which affects cristae organization and associates with the Parkinson’s disease-associated protein CHCHD2 in the inner mitochondrial membrane. We here used CRISPR-Cas9-mediated knockout HAP1 cells to shed further light on the function of TMBIM5 in physiology and cell death susceptibility. We found that compared to wild type, TMBIM5-knockout cells were smaller and had a slower proliferation rate. In these cells, mitochondria were more fragmented with a vacuolar cristae structure. In addition, the mitochondrial membrane potential was reduced and respiration was attenuated, leading to a reduced mitochondrial ATP generation. TMBIM5 did not associate with Mic10 and Mic60, which are proteins of the mitochondrial contact site and cristae organizing system (MICOS), nor did TMBIM5 knockout affect their expression levels. TMBIM5-knockout cells were more sensitive to apoptosis elicited by staurosporine and BH3 mimetic inhibitors of Bcl-2 and Bcl-XL. An unbiased proteomic comparison identified a dramatic downregulation of proteins involved in the mitochondrial protein synthesis machinery in TMBIM5-knockout cells. We conclude that TMBIM5 is important to maintain the mitochondrial structure and function possibly through the control of mitochondrial biogenesis.